Downregulation of IRF7-mediated type-I interferon response by LmCen–/– parasites is necessary for protective immunity

Leishmaniasis is a tropical disease caused by Leishmania parasites and currently has no licensed vaccines. We developed a dermotropic Leishmania major centrin gene-deleted strain (LmCen<sup>-/-</sup>) as a live attenuated vaccine. Recent studies have shown that type I interferons (IFNs) play important roles in immunity to parasitic and viral pathogens. However, their relevance in protective immunity following vaccination is not understood. We found that immunization with LmCen<sup>-/-</sup> induces a transient increase in type I IFN response along with its regulatory factor IRF7 that is downregulated 7-21 days post-immunization, coincided with the induction of a robust Th1 adaptive immune response. Challenge infection with virulent L. donovani parasites showed a significant reduction of splenic and hepatic parasite burden in IRF7<sup>-/-</sup> mice than wild type mice following immunization with LmCen<sup>-/-</sup>, suggesting that ablation of type I IFN response is a pre-requisite for the induction of LmCen<sup>-/-</sup> mediated Th1 immunity against L. donovani infection.

Authors

Institutions

Publication Details

Journal
npj Vaccines
Published
2024-12-19
DOI
https://doi.org/10.1038/s41541-024-01032-6
Citations
1
Primary Topic
Research on Leishmaniasis Studies
Type
article
Field-Weighted Citation Impact
0.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Downregulation of IRF7-mediated type-I interferon response by LmCen–/– parasites is necessary for protective immunity

Hira Lal Nakhasi, Telly Sepahpour, Abhay R. Satoskar, Shinjiro Hamano et al.
1 citations
npj Vaccines
Research on Leishmaniasis Studies
0.54
article

Downregulation of IRF7-mediated type-I interferon response by LmCen–/– parasites is necessary for protective immunity

Hira Lal Nakhasi, Telly Sepahpour, Abhay R. Satoskar, Shinjiro Hamano, Derek D.C. Ireland, Jalal Alshaweesh, Ranadhir Dey, Komudi Singh, Nazli Azodi, Sreenivas Gannavaram, Risa Nakamura, Farzaneh Valanezhad
article en
1 citations

Abstract

Leishmaniasis is a tropical disease caused by Leishmania parasites and currently has no licensed vaccines. We developed a dermotropic Leishmania major centrin gene-deleted strain (LmCen<sup>-/-</sup>) as a live attenuated vaccine. Recent studies have shown that type I interferons (IFNs) play important roles in immunity to parasitic and viral pathogens. However, their relevance in protective immunity following vaccination is not understood. We found that immunization with LmCen<sup>-/-</sup> induces a transient increase in type I IFN response along with its regulatory factor IRF7 that is downregulated 7-21 days post-immunization, coincided with the induction of a robust Th1 adaptive immune response. Challenge infection with virulent L. donovani parasites showed a significant reduction of splenic and hepatic parasite burden in IRF7<sup>-/-</sup> mice than wild type mice following immunization with LmCen<sup>-/-</sup>, suggesting that ablation of type I IFN response is a pre-requisite for the induction of LmCen<sup>-/-</sup> mediated Th1 immunity against L. donovani infection.

npj VaccinesVol. 9(1)
Center for Biologics Evaluation and Research (US), United States Food and Drug Administration (US), Center for Drug Evaluation and Research (US), National Heart, Lung, and Blood Institute (US), Nagasaki University (JP), The Ohio State University (US)
RIKEN
Good health and well-being
Openalex Percentile: Top 26%
Research on Leishmaniasis Studies
0.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.